Drug intelligence / Profile preview

Radix Rubiae topical preparation

Development stage: Unknown
Lead developer: The Chinese University of Hong Kong
Administration: Topical

Overview

Radix Rubiae topical preparation is an herbal-based therapeutic developed by the School of Chinese Medicine at the Chinese University of Hong Kong (CUHK) for the treatment of plaque-type psoriasis. Radix Rubiae, derived from the root of *Rubia cordifolia* (also known as Indian Madder or Qian Cao), has been traditionally used in Chinese medicine for its anti-inflammatory and blood-cooling properties. In the context of psoriasis, it is hypothesized to inhibit keratinocyte proliferation and modulate inflammatory pathways. The preparation is formulated for topical application to provide localized treatment for mild to moderate chronic plaque-type psoriasis.

Other names: Rubia cordifolia topical preparationQian Cao topical preparation

Beyond the preview

Go deeper on Radix Rubiae topical preparation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radix Rubiae topical preparation.

Explore the full profile